Phage display-derived peptides as therapeutic alternatives to antibodies.
about
Compstatin: a complement inhibitor on its way to clinical applicationIn Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid LibrariesImproving binding affinity and stability of peptide ligands by substituting glycines with D-amino acidsPEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityPhage protein-targeted cancer nanomedicines.The adsorption of preferential binding peptides to apatite-based materialsDevelopment of an optimized protocol for studying the interaction of filamentous bacteriophage with mammalian cells by fluorescence microscopyCombinatorial peptide libraries: mining for cell-binding peptides.Peptide aptamers: recent developments for cancer therapy.Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and dockingOptimizing the affinity and specificity of proteins with molecular display.Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1Trisubstituted (E)-alkene dipeptide isosteres as beta-turn promoters in the gramicidin S cyclodecapeptide scaffold.Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library.A novel method of ligand peptidomics to identify peptide ligands binding to AQP2-expressing plasma membranes and intracellular vesicles of rat kidney.Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Potential of phage-displayed peptide library technology to identify functional targeting peptidesSynthetic constrained peptide selectively binds and antagonizes death receptor 5.Identification of novel specific allosteric modulators of the glycine receptor using phage display.In vitro selection of a peptide inhibitor of human IL-6 using mRNA display.Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors.Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant.Bacterial display and screening of posttranslationally thioether-stabilized peptides.Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.Identification of heptapeptides interacting with IFN-α-sensitive CML cells.A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding.Phosphorylation-dependent mineral-type specificity for apatite-binding peptide sequencesMolecular mechanism of a novel CD59-binding peptide sp22 induced tumor cells apoptosis.Panning of a phage display library against a synthetic capsule for peptide ligands that bind to the native capsule of Bacillus anthracisHighly efficient selection of epitope specific antibody through competitive yeast display library sortingEngineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Bacteriophages and medical oncology: targeted gene therapy of cancer.EGFR-binding peptide: a patent evaluation of WO2014002836.Nanoparticle delivery of a peptide targeting EGFR signalingA mix-and-read drop-based in vitro two-hybrid method for screening high-affinity peptide bindersBinding of Hemagglutinin and Influenza Virus to a Peptide-Conjugated Lipid Membrane.
P2860
Q24658454-6F78FF45-04A8-4324-A4B5-FE08DAD75DF5Q26782129-3A5F8CF6-4404-4E22-926F-06563B6C4BDBQ27685175-D5A6B7AA-7D47-4C0D-93A3-F572FCE77FFEQ28741459-6043882D-7F40-4069-AD8E-DE274B1E423CQ30403553-F7A07BBB-E2E8-4245-8C09-D20E6E04ECBCQ30855233-CB50B953-BA76-471D-8D6B-CD95796F45BAQ30916441-BC0B6995-A355-4FB4-87FA-7AE878FB8F80Q31144876-CDEDB272-CE53-4A29-A6F5-E6623F95F799Q33216999-F21746D4-CF02-4390-AB49-22A1B10EA685Q33232878-773231A1-7A8C-4EE4-B478-4256D036BD30Q33252425-0EBF1932-3B52-4942-A629-7EAB92D9C449Q33256392-79E90911-06AE-4752-B0FC-FF5FE0F37640Q33259315-C498B558-4D3D-4CD9-BAA1-01AB82537488Q33301751-610C927C-0EC5-4DB4-84E2-915E3554F3B4Q33334773-E48C824E-93A2-4909-B6F0-742D6DAB508BQ33382036-2CF5F529-7D5B-4B49-8336-AD61341B7971Q33384724-C26C73C9-E5CE-4393-B094-39DDAE2B778EQ33520512-B673FCDC-8E8E-4014-8415-70C7E8481A97Q33530848-F2204A69-4E45-4CAB-9458-ECDC5F37AE55Q33531333-70481CE1-A829-44C3-BDD0-314314A16869Q33587125-B0082AED-7AB1-488E-97E2-8BE94C5AC498Q33764315-D7AA6AFF-5662-4991-9F8E-57F92DA9B559Q33770890-77B6AF1B-C03B-4B11-A783-E5AEB838CCA3Q33900072-5C556C7B-E03A-479B-B808-DBF30DC3C65FQ33913444-9C569E9E-680E-480D-8220-A6E541F5E150Q33984610-3720AABB-8D1A-4212-8A65-CDCF7081A6BCQ34042492-7E237202-A24F-42E0-BAAF-B8974BA9218FQ34076524-DD0A543B-BD19-491B-AA46-43465EE0DD1BQ34079353-A9779AFF-F6F0-4D67-AE4C-5474ABAAF911Q34089704-C941D0A2-477D-4907-9A06-1F38200BAB90Q34292950-9C079DD0-11D3-4BB5-9AA2-AD15E3651A15Q34347455-A3E5C35F-13B7-475B-BC7B-1EC67B170603Q34429143-6D039629-1841-4586-9FC2-4CF8B366614CQ34772027-DB29FA45-F3B3-4A1A-9A3E-63AD660931DAQ34787415-0E1227B5-C2ED-4839-92DC-4E57E4698A26Q35204972-E3DCA32E-B536-4FD0-AB50-0541223728A1Q35433987-DD0F2176-D248-400F-9846-D5D46A53A257Q35589627-6A6BA1E8-06D1-43AB-B49B-9E40F74D3D68Q35945330-F1E4CE97-EC67-4988-91F1-7145A21319B3Q35993384-EB378FC8-160E-4A2D-ABB7-ABF79B3F7D1F
P2860
Phage display-derived peptides as therapeutic alternatives to antibodies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phage display-derived peptides as therapeutic alternatives to antibodies.
@ast
Phage display-derived peptides as therapeutic alternatives to antibodies.
@en
type
label
Phage display-derived peptides as therapeutic alternatives to antibodies.
@ast
Phage display-derived peptides as therapeutic alternatives to antibodies.
@en
prefLabel
Phage display-derived peptides as therapeutic alternatives to antibodies.
@ast
Phage display-derived peptides as therapeutic alternatives to antibodies.
@en
P2093
P1433
P1476
Phage display-derived peptides as therapeutic alternatives to antibodies.
@en
P2093
Aaron K Sato
Jennifer Gorzelany
Mark de Souza
Robert C Ladner
P304
P356
10.1016/S1359-6446(04)03104-6
P577
2004-06-01T00:00:00Z